Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on November 5, 2026

Nov. 5, 2026

iMDx to Release Third Quarter Results on November 16, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Tenax Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

ProMIS Neurosciences to Participate in Upcoming Conferences in November

Indeterminate GlobeNewswire

Nov. 5, 2026

Kayak Therapeutics Announces IND Clearance for KT-300, a Potential First-in-Class TRIM7 Inhibitor for RAS-Driven Cancers

Indeterminate GlobeNewswire

Nov. 5, 2026

Monte Rosa Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

Enviri Corporation Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Astec Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Opus Genetics Completes Dosing in Cohort 2 of Phase 1/2 Clinical Trial of OPGx-BEST1 Gene Therapy for Inherited Retinal Diseases

Indeterminate GlobeNewswire

Nov. 5, 2026

Climb Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

Lantheus Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Vima Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial for Parkinson’s Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Indeterminate GlobeNewswire

Nov. 5, 2026

Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Iovance Biotherapeutics Reports Record Third Quarter 2026 Revenue of ~$122M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update 

Indeterminate GlobeNewswire

Nov. 5, 2026

HydroGraph to Showcase Graphene-Carbon Black Hybrid for Cost-Effective Conductive Compounds at AMI Plastics World Expo

Indeterminate GlobeNewswire

Nov. 5, 2026

Certara Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Apyx Medical Corporation Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Agility Becomes First U.S. Publicly Listed Pure-Play Humanoid Robotics Company, Begins Trading Today on Nasdaq as AGLT

Indeterminate GlobeNewswire